Background: COVID-19 pandemic has affected the management of multiple sclerosis (MS). Objective: To explore the impact of COVID-19 on healthcare delivery to people with MS and the subsequent recovery of the system. Methods: In this population-based study in the Campania Region (Italy), we included people with MS across pre-COVID-19, lockdown, pre-vaccination, and vaccination periods. Differences in continuous outcomes between periods were explored using linear mixed models (annualized hospitalization rate (AHR) and adherence measured as medication possession ratio (MPR)). Differences in disease-modifying treatment (DMT) prescription rates (first DMT prescription, any DMT switch, switch from platform to highly effective DMT, and combination of first DMT prescription and any DMT switch) were assessed using an interrupted time series design. Results: Compared with pre-COVID-19, AHR decreased during the lockdown (Coeff = 0.64;95%CI = -0.69, -0.59; p < 0.01), and remained lower during pre-vaccination and vaccination periods. Adherence decreased during pre-vaccination (Coeff = -0.04;95%CI = -0.05, -0.03; p < 0.01) and vaccination periods (Coeff = -0.07;95%CI = -0.08, -0.07; p < 0.01). After the lockdown, there was an increase in any DMT switch (IRR 2.05 95%CI 1.38,3.05; p < 0.01), in switch from platform to highly effective DMTs (IRR 4.45;95%CI 2.48,8.26; p < 0.01) and in first DMT prescriptions (IRR 2.48;95%CI 1.64,3.74; p < 0.01). Conclusions: DMT prescriptions quickly returned to pre-pandemic levels, reflecting good health system recovery. However, adherence has remained lower than the past, as from suboptimal care. Assessing long-term COVID-19 impact on MS healthcare is warranted.

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study / Affinito, Giuseppina; Trama, Ugo; Palumbo, Laura; Fumo, Maria Grazia; Giordana, Roberta; Di Gennaro, Massimo; Triassi, Maria; Lanzillo, Roberta; Morra, Vincenzo Brescia; Palladino, Raffaele; Moccia, Marcello. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-3478. - 44:11(2023). [10.1007/s10072-023-07052-9]

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study

Affinito, Giuseppina;Trama, Ugo;Fumo, Maria Grazia;Giordana, Roberta;Di Gennaro, Massimo;Triassi, Maria;Lanzillo, Roberta;Morra, Vincenzo Brescia;Palladino, Raffaele;Moccia, Marcello
2023

Abstract

Background: COVID-19 pandemic has affected the management of multiple sclerosis (MS). Objective: To explore the impact of COVID-19 on healthcare delivery to people with MS and the subsequent recovery of the system. Methods: In this population-based study in the Campania Region (Italy), we included people with MS across pre-COVID-19, lockdown, pre-vaccination, and vaccination periods. Differences in continuous outcomes between periods were explored using linear mixed models (annualized hospitalization rate (AHR) and adherence measured as medication possession ratio (MPR)). Differences in disease-modifying treatment (DMT) prescription rates (first DMT prescription, any DMT switch, switch from platform to highly effective DMT, and combination of first DMT prescription and any DMT switch) were assessed using an interrupted time series design. Results: Compared with pre-COVID-19, AHR decreased during the lockdown (Coeff = 0.64;95%CI = -0.69, -0.59; p < 0.01), and remained lower during pre-vaccination and vaccination periods. Adherence decreased during pre-vaccination (Coeff = -0.04;95%CI = -0.05, -0.03; p < 0.01) and vaccination periods (Coeff = -0.07;95%CI = -0.08, -0.07; p < 0.01). After the lockdown, there was an increase in any DMT switch (IRR 2.05 95%CI 1.38,3.05; p < 0.01), in switch from platform to highly effective DMTs (IRR 4.45;95%CI 2.48,8.26; p < 0.01) and in first DMT prescriptions (IRR 2.48;95%CI 1.64,3.74; p < 0.01). Conclusions: DMT prescriptions quickly returned to pre-pandemic levels, reflecting good health system recovery. However, adherence has remained lower than the past, as from suboptimal care. Assessing long-term COVID-19 impact on MS healthcare is warranted.
2023
Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study / Affinito, Giuseppina; Trama, Ugo; Palumbo, Laura; Fumo, Maria Grazia; Giordana, Roberta; Di Gennaro, Massimo; Triassi, Maria; Lanzillo, Roberta; Morra, Vincenzo Brescia; Palladino, Raffaele; Moccia, Marcello. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-3478. - 44:11(2023). [10.1007/s10072-023-07052-9]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/962017
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact